Skip to main content

UBS Group AG

Position in DMAC — DiaMedica Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in DMAC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$160,856
+$102,222 QoQ
Shares Held
22,849
+163.8% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 87 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in DMAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,365,122 across 562 Biotechnology names. DMAC ranks #344 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DMAC

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $160,856 22,849
2026-03-31 $58,634 8,661
2025-12-31 $28,702 3,606
2025-09-30 $91,645 13,340
2025-06-30 $32,237 8,266
2025-03-31 $16,607 4,382
2024-12-31 $9,604 1,769
2024-09-30 $53,376 12,739
2024-03-31 $5,335 1,926
2023-09-30 $216 84
2023-03-31 $3,118 2,038
2022-12-31 $5,936 3,757
2022-09-30 $8,916 7,191
2022-06-30 $6,120 3,030
2022-03-31 $2,375 950
2021-12-31 $17,225 4,618
2021-06-30 $92,181 20,715
2021-03-31 $9,607 1,050
2020-12-31 $9,267 914
2020-06-30 $4,081 589
2020-03-31 $23,800 8,500